1753-9447

Therapeutic Advances in Cardiovascular Disease

SAGE Publications

View prefix report (10.1177)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 373 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact373 DOIs
2

Add abstracts to 58 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact58 DOIs
3

Deposit reference lists for 21 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact21 DOIs

DOIs for this ISSN

Showing the top 5 of 525 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 RETRACTED: Differential expression of the angiotensin-(1-12)… (10.1177/1753944715589717)
Abstract References ORCID
100.68 21
2 Metabolic syndrome: pathophysiology, management, and modulat… (10.1177/1753944717711379)
ORCID
73.25 850
3 Editorial (10.1177/1753944707087409)
Abstract ORCID
70.75 25
4 The relationship of saturated fats and coronary heart diseas… (10.1177/1753944717742549)
Abstract ORCID
69.01 23
5 Acute myocardial infarction due to liquid nicotine in a youn… (10.1177/1753944713515765)
Abstract ORCID
61.52 16
6 New-onset lone atrial fibrillation in pregnancy (10.1177/1753944716644584)
Abstract ORCID
55.70 12
7 Review: Preeclampsia and future cardiovascular risk: formal… (10.1177/1753944708094227)
ORCID
54.33 148
8 Comparing the safety of ticagrelor <i>versus</i> clopidogrel… (10.1177/1753944712468627)
Abstract ORCID
53.96 11
9 ACE2 and vasoactive peptides: novel players in cardiovascula… (10.1177/1753944715597623)
ORCID
52.51 125
10 Challenges in management of left ventricular thrombus (10.1177/1753944717711139)
ORCID
52.34 123
11 The emerging role of endothelin-1 in the pathogenesis of pre… (10.1177/1753944715624853)
ORCID
51.03 109
12 Cardiac remodelling and RAS inhibition (10.1177/1753944716642677)
ORCID
50.73 106
13 Mechanisms of alcoholic heart disease (10.1177/1753944708095137)
ORCID
48.98 90
14 Review: Role of the augmentation index in hypertension (10.1177/1753944707086935)
ORCID
48.73 88
15 Original Research: Carotid intima-media thickness and plaque… (10.1177/1753944707085982)
ORCID
47.98 82
16 Pathophysiology, diagnosis, and management of aortic dissect… (10.1177/1753944708090830)
ORCID
47.98 82
17 Review: Stroke prevention: modifying risk factors (10.1177/1753944708093847)
ORCID
47.85 81
18 The role of cellular micronutrient analysis, nutraceuticals,… (10.1177/1753944710368205)
ORCID
47.44 78
19 Nanomedicine applied to cardiovascular diseases: latest deve… (10.1177/1753944717692293)
ORCID
47.44 78
20 Salvianolic acid B and Tanshinone IIA attenuate myocardial i… (10.1177/1753944710396538)
ORCID
47.16 76
21 Review: Systemic and uteroplacental renin—angiotensin system… (10.1177/1753944708094529)
ORCID
47.02 75
22 Left ventricular noncompaction cardiomyopathy: updated revie… (10.1177/1753944713504639)
ORCID
46.88 74
23 Burden of comorbidities among patients with atrial fibrillat… (10.1177/1753944712464101)
ORCID
46.43 71
24 Review: PPARs as new therapeutic targets for the treatment o… (10.1177/1753944708090924)
ORCID
46.13 69
25 Hyperglycemia in acute coronary syndromes: from mechanisms t… (10.1177/1753944715594528)
ORCID
45.97 68
26 Nitric oxide mechanisms of nebivolol (10.1177/1753944709104496)
ORCID
45.49 65
27 Validated formulae for estimation of whole blood viscosity u… (10.1177/1753944716642676)
Abstract ORCID
45.15 7
28 Review: The role of the L-arginine-nitric oxide pathway in p… (10.1177/1753944708092277)
ORCID
44.98 62
29 Adiponectin gene polymorphisms and their effect on the risk… (10.1177/1753944710371483)
ORCID
44.63 60
30 The role of chronic hyperviscosity in vascular disease (10.1177/1753944714553226)
ORCID
44.63 60
31 Review: Pulse pressure, arterial stiffness and wave reflecti… (10.1177/1753944707086652)
ORCID
43.51 54
32 Review: Vascular remodeling: implications for small artery f… (10.1177/1753944707086358)
ORCID
43.31 53
33 Pre-eclampsia: the pivotal role of the placenta in its patho… (10.1177/1753944708097114)
ORCID
43.31 53
34 Exploration of pharmacological interventions to prevent isop… (10.1177/1753944714531638)
ORCID
42.90 51
35 Epidemic of cardiometabolic diseases: a Latin American point… (10.1177/1753944711403189)
ORCID
42.69 50
36 Attenuation of isoproterenol-induced cardiac fibrosis in tra… (10.1177/1753944709353426)
ORCID
42.47 49
37 Update on platelet glycoprotein IIb/IIIa inhibitors: recomme… (10.1177/1753944713487781)
ORCID
42.47 49
38 The role of noninvasive cardiovascular testing, applied clin… (10.1177/1753944717743920)
ORCID
42.47 49
39 Perspective The failure of cholesteryl ester transfer protei… (10.1177/1753944714566427)
Abstract ORCID
42.25 6
40 Blood pressure treatment goals in hypertension (10.1177/1753944716636035)
Abstract ORCID
42.25 6
41 Understanding mechanisms of hypertension in systemic lupus e… (10.1177/1753944716637807)
ORCID
42.25 48
42 Review: Therapeutic potential of plasminogen activator inhib… (10.1177/1753944710379126)
ORCID
42.03 47
43 The role of endothelial cells and their progenitors in intim… (10.1177/1753944710362903)
ORCID
41.80 46
44 Taurine supplementation has anti-atherogenic and anti-inflam… (10.1177/1753944717711138)
ORCID
41.80 46
45 Some mechanical aspects of arterial aging: physiological ove… (10.1177/1753944709338942)
ORCID
41.09 43
46 Sevelamer revisited: pleiotropic effects on endothelial and… (10.1177/1753944713513061)
ORCID
41.09 43
47 New parenteral anticoagulants in development (10.1177/1753944710387808)
ORCID
40.84 42
48 Low dietary sodium intake is associated with enhanced vascul… (10.1177/1753944709345790)
ORCID
40.58 41
49 Review: Hypercholesterolemia-associated endothelial progenit… (10.1177/1753944708094769)
ORCID
40.32 40
50 Individualizing hypertension treatment with impedance cardio… (10.1177/1753944709348236)
ORCID
40.05 39